Rosenblum, PhD, A., R. A. Cruciani, MD, PhD, E. C. Strain, MD, C. M. Cleland, PhD, H. Joseph, PhD, S. Magura, PhD, CSW, L. A. Marsch, PhD, L. F. McNicholas, MD, PhD, S. R. Savage, MD, MS, A. Sundaram, BA, and R. K. Portenoy, MD. “Sublingual buprenorphine/Naloxone for Chronic Pain in at-Risk Patients: Development and Pilot Test of a Clinical Protocol”. Journal of Opioid Management, vol. 8, no. 6, Nov. 2012, pp. 369-82, doi:10.5055/jom.2012.0137a.